PSMA6 and renal cell carcinoma: However, the association of alpha-1 blocker exposure and RCC risk seen in patients without BPH was still high in male populations, not only in the subgroup with hypertension but also in the one without hypertension (HR, 2.31; 95% CI, 1.40−3.81; P < .001).